Swortwood, Madeleine JBartock, Sarah HScheidweiler, Karl BShaw, SophieFilis, PanagiotisDouglas, AlexO'Shaughnessy, Peter JSoffientini, UgoLucendo-Villarin, BaltasarIredale, John PHay, David CFowler , Paul AHuestis, Marilyn A2018-11-072018-11-072018-01Swortwood, M J, Bartock, S H, Scheidweiler, K B, Shaw, S, Filis, P, Douglas, A, O'Shaughnessy, P J, Soffientini, U, Lucendo-Villarin, B, Iredale, J P, Hay, D C, Fowler , P A & Huestis, M A 2018, 'Quantification of ethyl glucuronide, ethyl sulfate, nicotine, and its metabolites in human fetal liver and placenta', Forensic Toxicology, vol. 36, no. 1, pp. 102-112. https://doi.org/10.1007/s11419-017-0389-21860-8973ORCID: /0000-0002-4831-9075/work/40417122ORCID: /0000-0003-2367-2670/work/67378883ORCID: /0000-0001-6606-1058/work/103322159http://hdl.handle.net/2164/11404This research was supported by the Medical Research Council (UK) grant MR/L010011/1 and the Intramural Research Program at the National Institute on Drug Abuse of the National Institutes of Health. Paired fetal liver and placenta samples were graciously provided by the Joint Medical Research Council/Wellcome Trust (grant number 099175/Z/12/Z) Human Developmental Biology Resource (www.hdbr.org). The online version of this article (doi:10.1007/s11419-017-0389-2) contains supplementary material, which is available to authorized users.11247993engSDG 3 - Good Health and Well-beingethyl glucuronidenicotinefetal liverplacentapregnancyprenatal exposureR MedicineMedical Research Council (MRC)MR/L010011/1Wellcome Trust099175/Z/12/ZRJournal article10.1007/s11419-017-0389-2361